Please assess the completion status of the following clinical trial:

Trial Title: Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Participants must have histologically or cytologically confirmed invasive or in-situ carcinoma of the breast~* Participants must have undergone sentinel lymph node mapping or axillary dissection~* Participants must have had a pre-operative Perometer measurement, and consecutive measurement at 4-6 month intervals prior to the onset of low volume edema (\>5% from baseline)~* Age \> 18 years~* Life expectancy of greater than 1 year~* Participants must have a Perometer measurement of 5% or greater volume difference (RVC) to qualify for randomization~* Ability to understand and willingness to sign a written informed consent document~* Willingness to comply with required follow up Perometer measurements and clinical visits~Exclusion Criteria:~* Known metastatic disease or other locally advanced disease in the thoracic or cervical regions~* Any patient who will not be returning routinely for follow-up~* Known brain metastases will be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events~* History of primary lymphedema~* History of prior surgery or radiation to the head, neck, upper limb, or trunk~* Evidence that axillary lymph node malignancy is causing lymphedema due to recurrence as per physician discretion~* Any patient who has bilateral lymph node mapping or dissection~* Any patient with a current case of cellulitis~* Patients with a history of a different malignancy are ineligible except for the following circumstances. Individuals with a history of other malignancies are eligible if they have been disease-free for at least 5 years and are deemed by the investigator to be at low risk for recurrence of that malignancy. Individuals with the following cancer are eligible if diagnosed and treated within the past 5 years: cervical cancer in situ, and basal cell or squamous cell carcinoma of the skin

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1A (Type: NO_INTERVENTION): Mild Lymphedema: Only required to meet with the lymphedema physical therapist
- Group 1B (Type: ACTIVE_COMPARATOR): Mild Lymphedema: Fitted for compression sleeve
- Group 2A (Type: ACTIVE_COMPARATOR): Moderate lymphedema: Fitted with a compression sleeve
- Group 2B (Type: ACTIVE_COMPARATOR): Moderate Lymphedema: Fitted with compression sleeve and instructed to wear a short-stretch compression bandage

Based on this trial design, predict the completion outcome and termination type (if applicable).